Company Executives May Have Concealed Rezulin Dangers
July 1, 2002
According to a story in yesterday's Los Angeles Times, Warner-Lambert Company executives intentionally concealed pertinent information regarding the dangers of the diabetes medication Rezulin. Documents obtained by the newspaper reportedly indicate that company officials delayed informing physicians and health regulators about the drug's link to liver damage.
The U.S. Food and Drug Association (FDA) removed Rezulin from the market in 2000 after dozens of cases of liver failure were reported. Since its removal, the drug has been linked to hundreds of deaths worldwide. Pfizer Inc., which purchased Warner-Lambert in mid-2000, currently faces thousands of lawsuits filed by more than 5,000 former Rezulin users.
-- Article Courtesy of InjuryBoard.com
More ...
- Rezulin Case Settles After $43 Million Verdict
- Rezulin / Troglitazone
- Doctors Ignored Rezulin Warnings
.